We detected pathogenic somatic variants in genes of the mTOR pathway in three out of ten individuals with MCD (30%) and in two out of four patients with CNS tumors (50%) (for a summary see Table 2). The gene discussed is MTOR; the disease is central nervous system neoplasm.